3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urogenital Neoplasms
1
Prostatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Laryngeal Diseases
1
Genital Neoplasms, Male
1
Brain Neoplasms
1
Interventions
padeliporfin
4
sipuleucel-T
1
rucaparib
1
niraparib
1
luprolide acetate gel depot
1
apalutamide
1
Therapeutics
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Paclitaxel
1
Leuprolide
1
Imatinib Mesylate
1
Gemcitabine
1
Cisplatin
1
Chemical Fractionation
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Genital Neoplasms, Male
×
Chemical Fractionation
×
Clear all
NCT02319239
2020-10-28
ESKO
Tampere University Hospital
Phase NA
Completed
80 enrolled